Cell Research· 2019Q1
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
- 1,134citations
- Q1SCImago
- 2019year
Short summary
Sodium oligomannate (GV-971) reverses Alzheimer's disease (AD) progression by remodeling gut microbiota, reducing specific amino acids (phenylalanine and isoleucine), and suppressing neuroinflammation.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Biological Psychiatry
Biological PsychiatryNeuroscience